State of New Jersey Common Pension Fund D lessened its stake in Danaher Co. (NYSE:DHR – Free Report) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,596 shares of the conglomerate’s stock after selling 12,313 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Danaher were worth $68,559,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Fort Pitt Capital Group LLC boosted its holdings in Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after acquiring an additional 7,421 shares during the last quarter. Good Life Advisors LLC bought a new stake in Danaher in the 3rd quarter worth about $217,000. Oak Thistle LLC purchased a new stake in Danaher in the 2nd quarter valued at about $363,000. Harvest Portfolios Group Inc. lifted its position in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after buying an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co grew its holdings in shares of Danaher by 75.4% in the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after acquiring an additional 1,874 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insider Activity at Danaher
In related news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Danaher
Danaher Price Performance
Danaher stock traded down $0.71 during midday trading on Friday, hitting $245.39. 2,941,170 shares of the company’s stock were exchanged, compared to its average volume of 2,802,560. The stock has a 50-day moving average price of $264.89 and a two-hundred day moving average price of $260.77. Danaher Co. has a 52-week low of $192.35 and a 52-week high of $281.70. The company has a market cap of $177.24 billion, a P/E ratio of 46.83, a PEG ratio of 4.55 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- What Are the U.K. Market Holidays? How to Invest and Trade
- California Resources Stock Could Be a Huge Long-Term Winner
- Why Invest in 5G? How to Invest in 5G Stocks
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Pros And Cons Of Monthly Dividend Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.